Agentic automation, generative AI, and other forms of AI in healthcare have revolutionized patient care and operational efficiency by enabling advanced diagnostics, treatment personalization, and self-directed decision-making systems. However, challenges such as data privacy, algorithm bias and validation, regulatory compliance, and integration into existing workflows pose significant hurdles to widespread adoption.
In today’s episode, Sandy chats with Yan Chow, an expert in AI, automation, and healthcare tech, and the global healthcare leader for Automation Anywhere. Healthcare is a target-rich environment that offers opportunities everywhere to make healthcare more sustainable and more valuable for the future. They chat about how AI is being applied to healthcare and how it can benefit both healthcare workers and patients alike. He also talks about how AI doesn’t have to be so scary, but it is important to take AI adoption one step at a time. If you want to hear more about Automation Anywhere, check out their recordings at the ViVe Event website.
In this episode, they talk about:
An overview of Automation Anywhere and what they are doing
The main application of AI today
There is a labor shortage in healthcare even though the demand is increasing
What is agentic automation and how will it help people with healthcare?
Automations are doing the job more effectively than we would be able to do
Cross borders and the difference in regulations and rules
Is AI making patient biases better or worse?
Limiting data to avoid hallucinations and mistakes
It takes time to learn when and where to utilize AI
A Little About Yan:
Yan Chow, MD, MBA, is a leader in the AI, automation, and healthcare technology sectors. He joined Automation Anywhere in 2019 to launch its healthcare vertical, leveraging AI to automate routine tasks and enabling healthcare professionals to focus on patient care. Previously, Dr. Chow was Medical Director for Digital Medicine at Amgen, where he integrated digital technologies like wearable sensors and advanced analytics into clinical trials.
Before Amgen, Dr. Chow served as Chief Innovation Officer at Longview Technology Solutions, providing healthcare consulting services to major U.S. government clients. He also led the Innovation & Advanced Technology Group at Kaiser Permanente, overseeing emerging clinical information technologies and managing a significant innovation grant program.
In addition to his corporate roles, Dr. Chow has founded and advised several startups, including a venture-funded NLP analytics company with a successful exit. He holds three U.S. patents and was recognized as one of the top three healthcare innovators in the nation by Healthcare IT News in 2014. Dr. Chow earned his A.B. from Harvard, M.D. from UC San Diego and MBA from UC Berkeley.
